Product information and disease descriptionPlace of product in therapyApproaches to treatment
Care management intervention strategies
8 evidence topics · 6 sources
Summary
- Team-based care: The 2025 AHA/ACC guideline describes multidisciplinary team-based care, including pharmacists, nurses, and community health workers, as effective in addressing barriers to blood pressure control. In a meta-analysis of 19 studies (5,993 participants), team-based care lowered systolic blood pressure at 12 months by 10.5 mm Hg with non-physician medication titration and 5.0 mm Hg with physician titration compared with usual care; the non-physician titration strategy was estimated at $4,400 per QALY gained over 10 years.
- Pharmacist management: In a cluster-randomized trial of 319 Black men recruited in 52 barbershops, pharmacist-led drug management reduced systolic blood pressure by 21.6 mm Hg more than the control approach at 6 months. A model estimated that 50% uptake of pharmacist prescribing would save $1.137 trillion and 30.2 million life years over 30 years.
- Home blood pressure monitoring and adherence: The guideline states that home blood pressure monitoring improves office blood pressure control when combined with other interventions, and lists dose consolidation, single-pill combinations, pharmacist education, home monitoring with feedback, shared decision-making, and medication synchronization and reminders as evidence-based adherence strategies.
Team-based care: guideline
Team-based care: meta-analysis and cost-effectiveness
“Among 19 studies comprising 5,993 participants, the 12-month SBP change vs. usual care was −5.0 (95% confidence interval: −7.9 to −2.2) mmHg for TBC with physician titration and −10.5 (−16.2 to −4.8) mmHg for TBC with non-physician titration.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Relative to usual care at 10 years, TBC with non-physician titration was estimated to cost $95 (95% uncertainty interval: -$563 to $664) more per patient and gain 0.022 (0.003 to 0.042) QALYs, costing $4,400/QALY gained.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Pharmacist-led management: barbershop trial in Black men
“We enrolled a cohort of 319 black male patrons with systolic blood pressure of 140 mm Hg or more from 52 black-owned barbershops (nontraditional health care setting) in a cluster-randomized trial in which barbershops were assigned to a pharmacist-led intervention (in which barbers encouraged meetings in barbershops with specialty-trained pharmacists who prescribed drug therapy under a collaborative practice agreement with the participants’ doctors) or to an active control approach (in which barbers encouraged lifestyle modification and doctor appointments).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“At 6 months, the mean systolic blood pressure fell by 27.0 mm Hg (to 125.8 mm Hg) in the intervention group and by 9.3 mm Hg (to 145.4 mm Hg) in the control group; the mean reduction was 21.6 mm Hg greater with the intervention (95% confidence interval, 14.7 to 28.4; P<0.001).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Pharmacist prescribing: US cost-effectiveness
“In this simulated cost-effectiveness analysis of a 5-state Markov model, 50% uptake of a pharmacist-prescribing intervention to improve blood pressure control was associated with a $1.137 trillion in cost savings and could save an estimated 30.2 million life years over 30 years.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote